"Drugs like Ozempic and Wegovy had been covered under Medi-Cal, California's Medicaid program. Now, the state says patients who only take these GLP-1 drugs for weight loss, are no longer covered. The governor's office has said limiting Medi-Cal coverage for GLP-1s could save the state nearly $800 million by 2029. The state is moving forward with this plan, even though the Trump administration has announced an agreement that is supposed to reduce the cost of these drugs for government insurance programs in the coming years."
"Some providers are concerned about the effect this shift will have on patients taking the drugs for obesity, who will no longer have this coverage. Dr. Wayne Ho is a Los Angeles obesity specialist. He said patients could be at risk of regaining the weight. He said there's also the physical and mental health issues that can come with that, which range from high blood pressure to depression."
TSA requires payment online at pay.gov for applicable fees; travelers cannot pay TSA staff directly at the airport. California's Medi-Cal will no longer cover GLP-1 drugs when prescribed solely for weight loss, though coverage continues for patients with Type 2 diabetes or cardiovascular disease. The governor's office projects nearly $800 million in savings by 2029 from limiting GLP-1 coverage. The state proceeds despite a federal agreement intended to lower drug costs for government programs. Providers warn that patients may regain weight and face physical and mental health risks, prompting clinicians to pursue alternatives such as lifestyle changes, other medications, and bariatric surgery. Siskiyou County reached a partial settlement requiring the sheriff's office to adopt a traffic-stop policy banning racial targeting and pretextual stops.
Read at Kqed
Unable to calculate read time
Collection
[
|
...
]